Importantly, CLK2 overexpression resulted in increased expression of ARV7, while a positive trend for ARFL expression was observed.
← all excerpts
Targeting the CLK2/SRSF9 splicing axis in prostate cancer leads to decreased ARV7 expression.
1
—
—
Importantly, CLK2 overexpression resulted in increased expression of ARV7, while a positive trend for ARFL expression was observed.